US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 2.890
  • +0.035+1.23%
Close Apr 26 16:00 ET
  • 2.920
  • +0.030+1.03%
Post 18:34 ET
493.39MMarket Cap-1382P/E (TTM)

Allogene Therapeutics Key Stats

Allogene Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 14, 2024

Revenue(YoY)

-44.00K

-10.00%
EPS(YoY)

-0.54

+18.18%

Strong Buy

Apr 8, 2024

Allogene Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 10.430K--
--2024/Q1-- / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--
Nov 2, 20232023/Q343.000K / 9.600K--
Aug 2, 20232023/Q244.000K / 18.250K--
May 3, 20232023/Q152.000K / 6.690K--
Feb 28, 20232022/Q447.000K / 64.210K--
Nov 2, 20222022/Q349.000K / 12.570K--
Aug 9, 20222022/Q286.000K / 15.790K--
May 4, 20222022/Q161.000K / 7.140K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 10.430K--
--2024/Q1-- / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--
Nov 2, 20232023/Q343.000K / 9.600K--
Aug 2, 20232023/Q244.000K / 18.250K--
May 3, 20232023/Q152.000K / 6.690K--
Feb 28, 20232022/Q447.000K / 64.210K--
Nov 2, 20222022/Q349.000K / 12.570K--
Aug 9, 20222022/Q286.000K / 15.790K--
May 4, 20222022/Q161.000K / 7.140K--

Unlock Free Earnings Estimates

Allogene Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 8, 2024

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg